nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—CCL2—obesity	0.211	0.348	CbGaD
Danazol—SHBG—obesity	0.12	0.198	CbGaD
Danazol—AR—obesity	0.105	0.174	CbGaD
Danazol—CYP19A1—obesity	0.0881	0.146	CbGaD
Danazol—ESR1—obesity	0.0811	0.134	CbGaD
Danazol—CYP3A4—Sibutramine—obesity	0.0227	0.27	CbGbCtD
Danazol—CYP3A4—Benzphetamine—obesity	0.0172	0.204	CbGbCtD
Danazol—CYP3A4—Bupropion—obesity	0.0146	0.174	CbGbCtD
Danazol—CYP3A4—Orlistat—obesity	0.0119	0.142	CbGbCtD
Danazol—CYP3A4—Cimetidine—obesity	0.0108	0.128	CbGbCtD
Danazol—CCL2—tunica intima—obesity	0.00966	0.136	CbGeAlD
Danazol—CCL2—brown adipose tissue—obesity	0.0075	0.106	CbGeAlD
Danazol—CYP3A4—Topiramate—obesity	0.00704	0.0835	CbGbCtD
Danazol—PGR—ovarian follicle—obesity	0.00597	0.084	CbGeAlD
Danazol—CYP19A1—ovarian follicle—obesity	0.00537	0.0756	CbGeAlD
Danazol—ESR1—ovarian follicle—obesity	0.00467	0.0657	CbGeAlD
Danazol—GNRHR—hindbrain—obesity	0.00315	0.0443	CbGeAlD
Danazol—CCL2—gall bladder—obesity	0.00242	0.0341	CbGeAlD
Danazol—CCL2—islet of Langerhans—obesity	0.00159	0.0224	CbGeAlD
Danazol—CCL2—respiratory system—obesity	0.0015	0.0211	CbGeAlD
Danazol—SHBG—hindbrain—obesity	0.00143	0.0202	CbGeAlD
Danazol—GNRHR—pituitary gland—obesity	0.0013	0.0183	CbGeAlD
Danazol—PGR—hindbrain—obesity	0.00129	0.0182	CbGeAlD
Danazol—CCL2—adrenal cortex—obesity	0.00126	0.0177	CbGeAlD
Danazol—CCL2—cardiovascular system—obesity	0.00115	0.0162	CbGeAlD
Danazol—Norelgestromin—STS—obesity	0.00112	0.194	CrCbGaD
Danazol—CCL2—pituitary gland—obesity	0.00102	0.0143	CbGeAlD
Danazol—CCL2—adipose tissue—obesity	0.00101	0.0143	CbGeAlD
Danazol—ESR1—hindbrain—obesity	0.00101	0.0142	CbGeAlD
Danazol—GNRHR—endocrine gland—obesity	0.00101	0.0142	CbGeAlD
Danazol—CCL2—digestive system—obesity	0.000953	0.0134	CbGeAlD
Danazol—CCL2—adrenal gland—obesity	0.000908	0.0128	CbGeAlD
Danazol—PGR—respiratory system—obesity	0.000788	0.0111	CbGeAlD
Danazol—CCL2—endocrine gland—obesity	0.000788	0.0111	CbGeAlD
Danazol—CCL2—liver—obesity	0.00071	0.01	CbGeAlD
Danazol—SHBG—cardiovascular system—obesity	0.00067	0.00943	CbGeAlD
Danazol—ESR1—respiratory system—obesity	0.000616	0.00868	CbGeAlD
Danazol—PGR—cardiovascular system—obesity	0.000604	0.0085	CbGeAlD
Danazol—SHBG—pituitary gland—obesity	0.000593	0.00835	CbGeAlD
Danazol—SHBG—adipose tissue—obesity	0.000591	0.00832	CbGeAlD
Danazol—PGR—pituitary gland—obesity	0.000534	0.00753	CbGeAlD
Danazol—PGR—adipose tissue—obesity	0.000532	0.00749	CbGeAlD
Danazol—SHBG—adrenal gland—obesity	0.00053	0.00746	CbGeAlD
Danazol—AR—adrenal cortex—obesity	0.000527	0.00742	CbGeAlD
Danazol—AR—cardiovascular system—obesity	0.000481	0.00677	CbGeAlD
Danazol—CYP19A1—adipose tissue—obesity	0.000479	0.00674	CbGeAlD
Danazol—PGR—adrenal gland—obesity	0.000477	0.00672	CbGeAlD
Danazol—ESR1—cardiovascular system—obesity	0.000472	0.00665	CbGeAlD
Danazol—SHBG—endocrine gland—obesity	0.00046	0.00647	CbGeAlD
Danazol—CYP19A1—adrenal gland—obesity	0.00043	0.00605	CbGeAlD
Danazol—AR—pituitary gland—obesity	0.000426	0.006	CbGeAlD
Danazol—AR—adipose tissue—obesity	0.000424	0.00597	CbGeAlD
Danazol—ESR1—pituitary gland—obesity	0.000418	0.00589	CbGeAlD
Danazol—ESR1—adipose tissue—obesity	0.000416	0.00586	CbGeAlD
Danazol—SHBG—liver—obesity	0.000414	0.00583	CbGeAlD
Danazol—PGR—endocrine gland—obesity	0.000414	0.00583	CbGeAlD
Danazol—AR—digestive system—obesity	0.000399	0.00562	CbGeAlD
Danazol—Constipation—Phenylpropanolamine—obesity	0.000398	0.00346	CcSEcCtD
Danazol—Photosensitivity—Bupropion—obesity	0.000398	0.00346	CcSEcCtD
Danazol—Dizziness—Benzphetamine—obesity	0.000395	0.00344	CcSEcCtD
Danazol—Migraine—Sibutramine—obesity	0.000395	0.00343	CcSEcCtD
Danazol—Affect lability—Sibutramine—obesity	0.000395	0.00343	CcSEcCtD
Danazol—Gastroenteritis—Bupropion—obesity	0.000394	0.00343	CcSEcCtD
Danazol—Dyspepsia—Phentermine—obesity	0.000392	0.00341	CcSEcCtD
Danazol—ESR1—digestive system—obesity	0.000392	0.00552	CbGeAlD
Danazol—Headache—Methamphetamine—obesity	0.000389	0.00338	CcSEcCtD
Danazol—Arthralgia—Cimetidine—obesity	0.000385	0.00334	CcSEcCtD
Danazol—Fatigue—Phentermine—obesity	0.000384	0.00334	CcSEcCtD
Danazol—Prednisone—HSD11B1—obesity	0.000384	0.0665	CrCbGaD
Danazol—Nasal congestion—Bupropion—obesity	0.000384	0.00334	CcSEcCtD
Danazol—Anxiety—Cimetidine—obesity	0.000383	0.00333	CcSEcCtD
Danazol—Constipation—Phentermine—obesity	0.000381	0.00331	CcSEcCtD
Danazol—AR—adrenal gland—obesity	0.00038	0.00536	CbGeAlD
Danazol—Mood swings—Sibutramine—obesity	0.00038	0.0033	CcSEcCtD
Danazol—Abdominal pain upper—Orlistat—obesity	0.000378	0.00329	CcSEcCtD
Danazol—Tachycardia—Diethylpropion—obesity	0.000378	0.00329	CcSEcCtD
Danazol—Hyperhidrosis—Diethylpropion—obesity	0.000375	0.00326	CcSEcCtD
Danazol—Headache—Benzphetamine—obesity	0.000375	0.00326	CcSEcCtD
Danazol—ESR1—adrenal gland—obesity	0.000373	0.00526	CbGeAlD
Danazol—Cramp muscle—Orlistat—obesity	0.000373	0.00324	CcSEcCtD
Danazol—Dysphonia—Topiramate—obesity	0.000373	0.00324	CcSEcCtD
Danazol—CYP19A1—endocrine gland—obesity	0.000373	0.00525	CbGeAlD
Danazol—Visual disturbance—Bupropion—obesity	0.000369	0.00321	CcSEcCtD
Danazol—Acne—Topiramate—obesity	0.000365	0.00317	CcSEcCtD
Danazol—Thrombocytopenia—Cimetidine—obesity	0.000361	0.00314	CcSEcCtD
Danazol—Dizziness—Phendimetrazine—obesity	0.00036	0.00313	CcSEcCtD
Danazol—Tachycardia—Cimetidine—obesity	0.00036	0.00313	CcSEcCtD
Danazol—Nausea—Benzphetamine—obesity	0.000355	0.00309	CcSEcCtD
Danazol—Urticaria—Phentermine—obesity	0.000354	0.00308	CcSEcCtD
Danazol—Musculoskeletal discomfort—Diethylpropion—obesity	0.000353	0.00307	CcSEcCtD
Danazol—Pancreatitis—Orlistat—obesity	0.000351	0.00305	CcSEcCtD
Danazol—Amenorrhoea—Topiramate—obesity	0.000349	0.00304	CcSEcCtD
Danazol—Affect lability—Bupropion—obesity	0.000344	0.00299	CcSEcCtD
Danazol—Migraine—Bupropion—obesity	0.000344	0.00299	CcSEcCtD
Danazol—Eosinophilia—Sibutramine—obesity	0.000343	0.00298	CcSEcCtD
Danazol—Headache—Phendimetrazine—obesity	0.000341	0.00297	CcSEcCtD
Danazol—Dyspepsia—Diethylpropion—obesity	0.000341	0.00297	CcSEcCtD
Danazol—Musculoskeletal discomfort—Cimetidine—obesity	0.000336	0.00292	CcSEcCtD
Danazol—CYP19A1—liver—obesity	0.000336	0.00473	CbGeAlD
Danazol—Irritability—Bupropion—obesity	0.000334	0.0029	CcSEcCtD
Danazol—Constipation—Diethylpropion—obesity	0.000331	0.00288	CcSEcCtD
Danazol—Mood swings—Bupropion—obesity	0.000331	0.00288	CcSEcCtD
Danazol—AR—endocrine gland—obesity	0.00033	0.00464	CbGeAlD
Danazol—ESR1—endocrine gland—obesity	0.000324	0.00456	CbGeAlD
Danazol—Nausea—Phendimetrazine—obesity	0.000324	0.00281	CcSEcCtD
Danazol—Asthenia—Phentermine—obesity	0.00032	0.00278	CcSEcCtD
Danazol—Abdominal pain upper—Bupropion—obesity	0.000319	0.00278	CcSEcCtD
Danazol—Fatigue—Cimetidine—obesity	0.000318	0.00276	CcSEcCtD
Danazol—Photosensitivity reaction—Sibutramine—obesity	0.000316	0.00275	CcSEcCtD
Danazol—Constipation—Cimetidine—obesity	0.000315	0.00274	CcSEcCtD
Danazol—Weight increased—Sibutramine—obesity	0.000315	0.00274	CcSEcCtD
Danazol—Cramp muscle—Bupropion—obesity	0.000315	0.00274	CcSEcCtD
Danazol—Urticaria—Diethylpropion—obesity	0.000308	0.00268	CcSEcCtD
Danazol—Dizziness—Phenylpropanolamine—obesity	0.000308	0.00268	CcSEcCtD
Danazol—Acute coronary syndrome—Sibutramine—obesity	0.000305	0.00265	CcSEcCtD
Danazol—Myocardial infarction—Sibutramine—obesity	0.000303	0.00263	CcSEcCtD
Danazol—Levonorgestrel—SRD5A1—obesity	0.000301	0.0521	CrCbGaD
Danazol—AR—liver—obesity	0.000297	0.00419	CbGeAlD
Danazol—Sweating—Sibutramine—obesity	0.000296	0.00258	CcSEcCtD
Danazol—Pancreatitis—Bupropion—obesity	0.000296	0.00257	CcSEcCtD
Danazol—Vomiting—Phenylpropanolamine—obesity	0.000296	0.00257	CcSEcCtD
Danazol—Dizziness—Phentermine—obesity	0.000295	0.00256	CcSEcCtD
Danazol—Haematuria—Sibutramine—obesity	0.000295	0.00256	CcSEcCtD
Danazol—Rash—Phenylpropanolamine—obesity	0.000294	0.00255	CcSEcCtD
Danazol—Dermatitis—Phenylpropanolamine—obesity	0.000293	0.00255	CcSEcCtD
Danazol—ESR1—liver—obesity	0.000292	0.00411	CbGeAlD
Danazol—Body temperature increased—Cimetidine—obesity	0.000292	0.00253	CcSEcCtD
Danazol—Fluid retention—Topiramate—obesity	0.000291	0.00253	CcSEcCtD
Danazol—Haemoglobin—Orlistat—obesity	0.000288	0.0025	CcSEcCtD
Danazol—Haemorrhage—Orlistat—obesity	0.000287	0.00249	CcSEcCtD
Danazol—Vomiting—Phentermine—obesity	0.000283	0.00246	CcSEcCtD
Danazol—Rash—Phentermine—obesity	0.000281	0.00244	CcSEcCtD
Danazol—Dermatitis—Phentermine—obesity	0.000281	0.00244	CcSEcCtD
Danazol—Headache—Phentermine—obesity	0.000279	0.00243	CcSEcCtD
Danazol—Haemoglobin—Sibutramine—obesity	0.000279	0.00242	CcSEcCtD
Danazol—Haemorrhage—Sibutramine—obesity	0.000277	0.00241	CcSEcCtD
Danazol—Nausea—Phenylpropanolamine—obesity	0.000277	0.0024	CcSEcCtD
Danazol—Photosensitivity reaction—Bupropion—obesity	0.000276	0.0024	CcSEcCtD
Danazol—Weight increased—Bupropion—obesity	0.000275	0.00239	CcSEcCtD
Danazol—Visual impairment—Sibutramine—obesity	0.000267	0.00232	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Bupropion—obesity	0.000267	0.00232	CcSEcCtD
Danazol—Acute coronary syndrome—Bupropion—obesity	0.000266	0.00231	CcSEcCtD
Danazol—Nausea—Phentermine—obesity	0.000265	0.0023	CcSEcCtD
Danazol—Asthenia—Cimetidine—obesity	0.000265	0.0023	CcSEcCtD
Danazol—Myocardial infarction—Bupropion—obesity	0.000264	0.0023	CcSEcCtD
Danazol—Jaundice—Bupropion—obesity	0.000263	0.00228	CcSEcCtD
Danazol—Sweating—Bupropion—obesity	0.000258	0.00224	CcSEcCtD
Danazol—Sleep disorder—Topiramate—obesity	0.000257	0.00224	CcSEcCtD
Danazol—Dizziness—Diethylpropion—obesity	0.000256	0.00223	CcSEcCtD
Danazol—Alopecia—Orlistat—obesity	0.000253	0.0022	CcSEcCtD
Danazol—Stanozolol—AR—obesity	0.000251	0.0436	CrCbGaD
Danazol—Gastroenteritis—Topiramate—obesity	0.000251	0.00218	CcSEcCtD
Danazol—Chills—Sibutramine—obesity	0.000249	0.00216	CcSEcCtD
Danazol—Vomiting—Diethylpropion—obesity	0.000246	0.00214	CcSEcCtD
Danazol—Alopecia—Sibutramine—obesity	0.000245	0.00213	CcSEcCtD
Danazol—Nasal congestion—Topiramate—obesity	0.000244	0.00213	CcSEcCtD
Danazol—Rash—Diethylpropion—obesity	0.000244	0.00212	CcSEcCtD
Danazol—Dermatitis—Diethylpropion—obesity	0.000244	0.00212	CcSEcCtD
Danazol—Dizziness—Cimetidine—obesity	0.000244	0.00212	CcSEcCtD
Danazol—Haemoglobin—Bupropion—obesity	0.000243	0.00211	CcSEcCtD
Danazol—Headache—Diethylpropion—obesity	0.000243	0.00211	CcSEcCtD
Danazol—Haemorrhage—Bupropion—obesity	0.000242	0.0021	CcSEcCtD
Danazol—Back pain—Orlistat—obesity	0.000241	0.0021	CcSEcCtD
Danazol—Muscle spasms—Orlistat—obesity	0.00024	0.00209	CcSEcCtD
Danazol—Tension—Sibutramine—obesity	0.000237	0.00206	CcSEcCtD
Danazol—Vision blurred—Orlistat—obesity	0.000235	0.00204	CcSEcCtD
Danazol—Visual disturbance—Topiramate—obesity	0.000235	0.00204	CcSEcCtD
Danazol—Nervousness—Sibutramine—obesity	0.000235	0.00204	CcSEcCtD
Danazol—Vomiting—Cimetidine—obesity	0.000235	0.00204	CcSEcCtD
Danazol—Back pain—Sibutramine—obesity	0.000234	0.00203	CcSEcCtD
Danazol—Visual impairment—Bupropion—obesity	0.000233	0.00203	CcSEcCtD
Danazol—Rash—Cimetidine—obesity	0.000233	0.00202	CcSEcCtD
Danazol—Dermatitis—Cimetidine—obesity	0.000232	0.00202	CcSEcCtD
Danazol—Muscle spasms—Sibutramine—obesity	0.000232	0.00202	CcSEcCtD
Danazol—Headache—Cimetidine—obesity	0.000231	0.00201	CcSEcCtD
Danazol—Nausea—Diethylpropion—obesity	0.00023	0.002	CcSEcCtD
Danazol—Erythema multiforme—Bupropion—obesity	0.000229	0.00199	CcSEcCtD
Danazol—Vision blurred—Sibutramine—obesity	0.000228	0.00198	CcSEcCtD
Danazol—Oxandrolone—AR—obesity	0.000226	0.0392	CrCbGaD
Danazol—Tremor—Sibutramine—obesity	0.000226	0.00197	CcSEcCtD
Danazol—Flushing—Bupropion—obesity	0.000224	0.00195	CcSEcCtD
Danazol—Vertigo—Orlistat—obesity	0.000224	0.00195	CcSEcCtD
Danazol—Palpitations—Orlistat—obesity	0.00022	0.00192	CcSEcCtD
Danazol—Migraine—Topiramate—obesity	0.000219	0.00191	CcSEcCtD
Danazol—Affect lability—Topiramate—obesity	0.000219	0.00191	CcSEcCtD
Danazol—Nausea—Cimetidine—obesity	0.000219	0.0019	CcSEcCtD
Danazol—CYP3A4—digestive system—obesity	0.000219	0.00308	CbGeAlD
Danazol—Chills—Bupropion—obesity	0.000217	0.00189	CcSEcCtD
Danazol—Vertigo—Sibutramine—obesity	0.000217	0.00189	CcSEcCtD
Danazol—Syncope—Sibutramine—obesity	0.000217	0.00188	CcSEcCtD
Danazol—Convulsion—Orlistat—obesity	0.000216	0.00188	CcSEcCtD
Danazol—Leukopenia—Sibutramine—obesity	0.000216	0.00188	CcSEcCtD
Danazol—Alopecia—Bupropion—obesity	0.000214	0.00186	CcSEcCtD
Danazol—Palpitations—Sibutramine—obesity	0.000213	0.00185	CcSEcCtD
Danazol—Irritability—Topiramate—obesity	0.000213	0.00185	CcSEcCtD
Danazol—Loss of consciousness—Sibutramine—obesity	0.000212	0.00184	CcSEcCtD
Danazol—Anxiety—Orlistat—obesity	0.000212	0.00184	CcSEcCtD
Danazol—Mood swings—Topiramate—obesity	0.000211	0.00183	CcSEcCtD
Danazol—Convulsion—Sibutramine—obesity	0.000209	0.00182	CcSEcCtD
Danazol—Hypertension—Sibutramine—obesity	0.000208	0.00181	CcSEcCtD
Danazol—Tension—Bupropion—obesity	0.000207	0.0018	CcSEcCtD
Danazol—Arthralgia—Sibutramine—obesity	0.000206	0.00179	CcSEcCtD
Danazol—Anxiety—Sibutramine—obesity	0.000205	0.00178	CcSEcCtD
Danazol—Nervousness—Bupropion—obesity	0.000204	0.00178	CcSEcCtD
Danazol—Oedema—Orlistat—obesity	0.000204	0.00177	CcSEcCtD
Danazol—Back pain—Bupropion—obesity	0.000204	0.00177	CcSEcCtD
Danazol—Abdominal pain upper—Topiramate—obesity	0.000203	0.00177	CcSEcCtD
Danazol—Muscle spasms—Bupropion—obesity	0.000202	0.00176	CcSEcCtD
Danazol—Vision blurred—Bupropion—obesity	0.000198	0.00172	CcSEcCtD
Danazol—Trilostane—ESR2—obesity	0.000197	0.0342	CrCbGaD
Danazol—Tremor—Bupropion—obesity	0.000197	0.00171	CcSEcCtD
Danazol—Oedema—Sibutramine—obesity	0.000197	0.00171	CcSEcCtD
Danazol—Hyperhidrosis—Orlistat—obesity	0.000197	0.00171	CcSEcCtD
Danazol—Shock—Sibutramine—obesity	0.000194	0.00169	CcSEcCtD
Danazol—Thrombocytopenia—Sibutramine—obesity	0.000193	0.00168	CcSEcCtD
Danazol—Tachycardia—Sibutramine—obesity	0.000192	0.00167	CcSEcCtD
Danazol—Eosinophilia—Topiramate—obesity	0.000191	0.00166	CcSEcCtD
Danazol—Hyperhidrosis—Sibutramine—obesity	0.000191	0.00166	CcSEcCtD
Danazol—Vertigo—Bupropion—obesity	0.000189	0.00164	CcSEcCtD
Danazol—Syncope—Bupropion—obesity	0.000189	0.00164	CcSEcCtD
Danazol—Pancreatitis—Topiramate—obesity	0.000189	0.00164	CcSEcCtD
Danazol—Leukopenia—Bupropion—obesity	0.000188	0.00164	CcSEcCtD
Danazol—Palpitations—Bupropion—obesity	0.000186	0.00162	CcSEcCtD
Danazol—Musculoskeletal discomfort—Orlistat—obesity	0.000186	0.00161	CcSEcCtD
Danazol—Loss of consciousness—Bupropion—obesity	0.000185	0.00161	CcSEcCtD
Danazol—Paraesthesia—Orlistat—obesity	0.000183	0.00159	CcSEcCtD
Danazol—Convulsion—Bupropion—obesity	0.000182	0.00159	CcSEcCtD
Danazol—Hypertension—Bupropion—obesity	0.000182	0.00158	CcSEcCtD
Danazol—CYP3A4—endocrine gland—obesity	0.000181	0.00254	CbGeAlD
Danazol—Musculoskeletal discomfort—Sibutramine—obesity	0.00018	0.00156	CcSEcCtD
Danazol—Dyspepsia—Orlistat—obesity	0.000179	0.00156	CcSEcCtD
Danazol—Arthralgia—Bupropion—obesity	0.000179	0.00156	CcSEcCtD
Danazol—Anxiety—Bupropion—obesity	0.000179	0.00155	CcSEcCtD
Danazol—Desogestrel—SHBG—obesity	0.000178	0.0308	CrCbGaD
Danazol—Paraesthesia—Sibutramine—obesity	0.000177	0.00154	CcSEcCtD
Danazol—Photosensitivity reaction—Topiramate—obesity	0.000176	0.00153	CcSEcCtD
Danazol—Fatigue—Orlistat—obesity	0.000176	0.00153	CcSEcCtD
Danazol—Weight increased—Topiramate—obesity	0.000175	0.00152	CcSEcCtD
Danazol—Dyspepsia—Sibutramine—obesity	0.000173	0.00151	CcSEcCtD
Danazol—Oedema—Bupropion—obesity	0.000172	0.00149	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Topiramate—obesity	0.00017	0.00148	CcSEcCtD
Danazol—Shock—Bupropion—obesity	0.000169	0.00147	CcSEcCtD
Danazol—Constipation—Sibutramine—obesity	0.000169	0.00146	CcSEcCtD
Danazol—Thrombocytopenia—Bupropion—obesity	0.000168	0.00146	CcSEcCtD
Danazol—Tachycardia—Bupropion—obesity	0.000168	0.00146	CcSEcCtD
Danazol—Hyperhidrosis—Bupropion—obesity	0.000166	0.00144	CcSEcCtD
Danazol—Haematuria—Topiramate—obesity	0.000164	0.00142	CcSEcCtD
Danazol—CYP3A4—liver—obesity	0.000163	0.00229	CbGeAlD
Danazol—Urticaria—Orlistat—obesity	0.000162	0.00141	CcSEcCtD
Danazol—Body temperature increased—Orlistat—obesity	0.000161	0.0014	CcSEcCtD
Danazol—Quinestrol—ESR1—obesity	0.00016	0.0278	CrCbGaD
Danazol—Urticaria—Sibutramine—obesity	0.000157	0.00136	CcSEcCtD
Danazol—Musculoskeletal discomfort—Bupropion—obesity	0.000157	0.00136	CcSEcCtD
Danazol—Body temperature increased—Sibutramine—obesity	0.000156	0.00135	CcSEcCtD
Danazol—Haemoglobin—Topiramate—obesity	0.000155	0.00135	CcSEcCtD
Danazol—Paraesthesia—Bupropion—obesity	0.000154	0.00134	CcSEcCtD
Danazol—Haemorrhage—Topiramate—obesity	0.000154	0.00134	CcSEcCtD
Danazol—Dyspepsia—Bupropion—obesity	0.000151	0.00131	CcSEcCtD
Danazol—Ethinyl Estradiol—NR1I2—obesity	0.000149	0.0259	CrCbGaD
Danazol—Visual impairment—Topiramate—obesity	0.000148	0.00129	CcSEcCtD
Danazol—Fatigue—Bupropion—obesity	0.000148	0.00129	CcSEcCtD
Danazol—Constipation—Bupropion—obesity	0.000147	0.00128	CcSEcCtD
Danazol—Asthenia—Orlistat—obesity	0.000146	0.00127	CcSEcCtD
Danazol—Erythema multiforme—Topiramate—obesity	0.000146	0.00127	CcSEcCtD
Danazol—Pruritus—Orlistat—obesity	0.000144	0.00125	CcSEcCtD
Danazol—Etonogestrel—SHBG—obesity	0.000144	0.0249	CrCbGaD
Danazol—Flushing—Topiramate—obesity	0.000143	0.00124	CcSEcCtD
Danazol—Testolactone—CYP19A1—obesity	0.000141	0.0245	CrCbGaD
Danazol—Asthenia—Sibutramine—obesity	0.000141	0.00123	CcSEcCtD
Danazol—Pruritus—Sibutramine—obesity	0.000139	0.00121	CcSEcCtD
Danazol—Chills—Topiramate—obesity	0.000138	0.0012	CcSEcCtD
Danazol—Urticaria—Bupropion—obesity	0.000136	0.00119	CcSEcCtD
Danazol—Alopecia—Topiramate—obesity	0.000136	0.00118	CcSEcCtD
Danazol—Body temperature increased—Bupropion—obesity	0.000136	0.00118	CcSEcCtD
Danazol—Dizziness—Orlistat—obesity	0.000135	0.00117	CcSEcCtD
Danazol—Tension—Topiramate—obesity	0.000132	0.00114	CcSEcCtD
Danazol—Dizziness—Sibutramine—obesity	0.00013	0.00113	CcSEcCtD
Danazol—Nervousness—Topiramate—obesity	0.00013	0.00113	CcSEcCtD
Danazol—Back pain—Topiramate—obesity	0.00013	0.00113	CcSEcCtD
Danazol—Vomiting—Orlistat—obesity	0.000129	0.00113	CcSEcCtD
Danazol—Muscle spasms—Topiramate—obesity	0.000129	0.00112	CcSEcCtD
Danazol—Rash—Orlistat—obesity	0.000128	0.00112	CcSEcCtD
Danazol—Dermatitis—Orlistat—obesity	0.000128	0.00112	CcSEcCtD
Danazol—Headache—Orlistat—obesity	0.000128	0.00111	CcSEcCtD
Danazol—Vision blurred—Topiramate—obesity	0.000126	0.0011	CcSEcCtD
Danazol—Tremor—Topiramate—obesity	0.000126	0.00109	CcSEcCtD
Danazol—Vomiting—Sibutramine—obesity	0.000125	0.00109	CcSEcCtD
Danazol—Rash—Sibutramine—obesity	0.000124	0.00108	CcSEcCtD
Danazol—Dermatitis—Sibutramine—obesity	0.000124	0.00108	CcSEcCtD
Danazol—Headache—Sibutramine—obesity	0.000123	0.00107	CcSEcCtD
Danazol—Asthenia—Bupropion—obesity	0.000123	0.00107	CcSEcCtD
Danazol—Testosterone Propionate—COMT—obesity	0.000123	0.0213	CrCbGaD
Danazol—Mestranol—ESR1—obesity	0.000122	0.0211	CrCbGaD
Danazol—Trilostane—ESR1—obesity	0.000122	0.0211	CrCbGaD
Danazol—Pruritus—Bupropion—obesity	0.000122	0.00106	CcSEcCtD
Danazol—Nausea—Orlistat—obesity	0.000121	0.00105	CcSEcCtD
Danazol—Vertigo—Topiramate—obesity	0.00012	0.00105	CcSEcCtD
Danazol—Syncope—Topiramate—obesity	0.00012	0.00105	CcSEcCtD
Danazol—Desogestrel—ESR1—obesity	0.00012	0.0208	CrCbGaD
Danazol—Leukopenia—Topiramate—obesity	0.00012	0.00104	CcSEcCtD
Danazol—Palpitations—Topiramate—obesity	0.000119	0.00103	CcSEcCtD
Danazol—Loss of consciousness—Topiramate—obesity	0.000118	0.00102	CcSEcCtD
Danazol—Nausea—Sibutramine—obesity	0.000117	0.00102	CcSEcCtD
Danazol—Convulsion—Topiramate—obesity	0.000116	0.00101	CcSEcCtD
Danazol—Hypertension—Topiramate—obesity	0.000116	0.00101	CcSEcCtD
Danazol—Arthralgia—Topiramate—obesity	0.000114	0.000993	CcSEcCtD
Danazol—Anxiety—Topiramate—obesity	0.000114	0.000989	CcSEcCtD
Danazol—Dizziness—Bupropion—obesity	0.000114	0.000988	CcSEcCtD
Danazol—Oedema—Topiramate—obesity	0.000109	0.000951	CcSEcCtD
Danazol—Vomiting—Bupropion—obesity	0.000109	0.00095	CcSEcCtD
Danazol—Rash—Bupropion—obesity	0.000108	0.000942	CcSEcCtD
Danazol—Dermatitis—Bupropion—obesity	0.000108	0.000941	CcSEcCtD
Danazol—Shock—Topiramate—obesity	0.000108	0.000936	CcSEcCtD
Danazol—Headache—Bupropion—obesity	0.000108	0.000936	CcSEcCtD
Danazol—Thrombocytopenia—Topiramate—obesity	0.000107	0.000932	CcSEcCtD
Danazol—Tachycardia—Topiramate—obesity	0.000107	0.000929	CcSEcCtD
Danazol—Hyperhidrosis—Topiramate—obesity	0.000106	0.00092	CcSEcCtD
Danazol—Nausea—Bupropion—obesity	0.000102	0.000887	CcSEcCtD
Danazol—Levonorgestrel—SHBG—obesity	0.000102	0.0176	CrCbGaD
Danazol—Musculoskeletal discomfort—Topiramate—obesity	9.97e-05	0.000867	CcSEcCtD
Danazol—Paraesthesia—Topiramate—obesity	9.83e-05	0.000854	CcSEcCtD
Danazol—Etonogestrel—ESR1—obesity	9.72e-05	0.0168	CrCbGaD
Danazol—Fluoxymesterone—SHBG—obesity	9.71e-05	0.0168	CrCbGaD
Danazol—Dyspepsia—Topiramate—obesity	9.63e-05	0.000838	CcSEcCtD
Danazol—Fatigue—Topiramate—obesity	9.44e-05	0.00082	CcSEcCtD
Danazol—Ethinyl Estradiol—ESR2—obesity	9.41e-05	0.0163	CrCbGaD
Danazol—Constipation—Topiramate—obesity	9.36e-05	0.000814	CcSEcCtD
Danazol—Testosterone Propionate—AR—obesity	9.18e-05	0.0159	CrCbGaD
Danazol—Levonorgestrel—AR—obesity	8.93e-05	0.0155	CrCbGaD
Danazol—Cortisone acetate—NR3C1—obesity	8.82e-05	0.0153	CrCbGaD
Danazol—Urticaria—Topiramate—obesity	8.7e-05	0.000756	CcSEcCtD
Danazol—Body temperature increased—Topiramate—obesity	8.65e-05	0.000752	CcSEcCtD
Danazol—Ethinyl Estradiol—SHBG—obesity	8.58e-05	0.0149	CrCbGaD
Danazol—Fluoxymesterone—AR—obesity	8.51e-05	0.0147	CrCbGaD
Danazol—Norethindrone—SHBG—obesity	8.25e-05	0.0143	CrCbGaD
Danazol—Asthenia—Topiramate—obesity	7.85e-05	0.000683	CcSEcCtD
Danazol—Methyltestosterone—SHBG—obesity	7.84e-05	0.0136	CrCbGaD
Danazol—Pruritus—Topiramate—obesity	7.74e-05	0.000673	CcSEcCtD
Danazol—Levonorgestrel—CYP19A1—obesity	7.47e-05	0.0129	CrCbGaD
Danazol—Dizziness—Topiramate—obesity	7.24e-05	0.000629	CcSEcCtD
Danazol—Vomiting—Topiramate—obesity	6.96e-05	0.000605	CcSEcCtD
Danazol—Rash—Topiramate—obesity	6.9e-05	0.0006	CcSEcCtD
Danazol—Dermatitis—Topiramate—obesity	6.89e-05	0.000599	CcSEcCtD
Danazol—Levonorgestrel—ESR1—obesity	6.88e-05	0.0119	CrCbGaD
Danazol—Methyltestosterone—AR—obesity	6.87e-05	0.0119	CrCbGaD
Danazol—Headache—Topiramate—obesity	6.86e-05	0.000596	CcSEcCtD
Danazol—Fluoxymesterone—ESR1—obesity	6.56e-05	0.0114	CrCbGaD
Danazol—Nausea—Topiramate—obesity	6.5e-05	0.000565	CcSEcCtD
Danazol—Hydrocortisone—SHBG—obesity	5.9e-05	0.0102	CrCbGaD
Danazol—Ethinyl Estradiol—ESR1—obesity	5.8e-05	0.01	CrCbGaD
Danazol—Fluoxymesterone—NR3C1—obesity	5.77e-05	0.01	CrCbGaD
Danazol—Methyltestosterone—CYP19A1—obesity	5.75e-05	0.00997	CrCbGaD
Danazol—Prednisone—NR3C1—obesity	4.98e-05	0.00863	CrCbGaD
Danazol—Progesterone—SHBG—obesity	4.81e-05	0.00833	CrCbGaD
Danazol—Progesterone—SLC22A1—obesity	4.75e-05	0.00822	CrCbGaD
Danazol—Testosterone—SHBG—obesity	4.55e-05	0.00788	CrCbGaD
Danazol—Testosterone—SLC22A1—obesity	4.49e-05	0.00777	CrCbGaD
Danazol—Progesterone—AR—obesity	4.22e-05	0.00731	CrCbGaD
Danazol—Testosterone—AR—obesity	3.99e-05	0.00691	CrCbGaD
Danazol—Hydrocortisone—NR3C1—obesity	3.51e-05	0.00608	CrCbGaD
Danazol—Testosterone—CYP19A1—obesity	3.34e-05	0.00578	CrCbGaD
Danazol—Progesterone—ESR1—obesity	3.25e-05	0.00563	CrCbGaD
Danazol—Progesterone—NR3C1—obesity	2.86e-05	0.00495	CrCbGaD
Danazol—Prednisone—ALB—obesity	2.52e-05	0.00436	CrCbGaD
Danazol—Norethindrone—ALB—obesity	2.48e-05	0.0043	CrCbGaD
Danazol—Methyltestosterone—ALB—obesity	2.36e-05	0.00408	CrCbGaD
Danazol—Testosterone—ALB—obesity	1.37e-05	0.00237	CrCbGaD
Danazol—PGR—Signaling Pathways—AGT—obesity	5.87e-06	4.94e-05	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—obesity	5.85e-06	4.93e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR3C1—obesity	5.84e-06	4.91e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK8—obesity	5.83e-06	4.91e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—obesity	5.81e-06	4.89e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—obesity	5.76e-06	4.85e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NTRK2—obesity	5.76e-06	4.85e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GNAS—obesity	5.75e-06	4.84e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—LEP—obesity	5.75e-06	4.84e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOE—obesity	5.75e-06	4.84e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB1—obesity	5.73e-06	4.82e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PRKCD—obesity	5.7e-06	4.8e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CAV1—obesity	5.7e-06	4.8e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—APOA1—obesity	5.68e-06	4.79e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LIPE—obesity	5.64e-06	4.75e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MUT—obesity	5.64e-06	4.75e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOB—obesity	5.63e-06	4.74e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PARP1—obesity	5.61e-06	4.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GHRL—obesity	5.61e-06	4.72e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DRD4—obesity	5.56e-06	4.68e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ESR1—obesity	5.49e-06	4.62e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MMP9—obesity	5.48e-06	4.61e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARA—obesity	5.47e-06	4.6e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRKCB—obesity	5.42e-06	4.56e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—F2—obesity	5.42e-06	4.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DGAT1—obesity	5.4e-06	4.55e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYB5A—obesity	5.4e-06	4.55e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—LPL—obesity	5.38e-06	4.53e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BAD—obesity	5.36e-06	4.51e-05	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—obesity	5.35e-06	4.51e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK8—obesity	5.33e-06	4.49e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—obesity	5.33e-06	4.49e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—obesity	5.31e-06	4.47e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CNR1—obesity	5.31e-06	4.47e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—SERPINE1—obesity	5.29e-06	4.45e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GPX1—obesity	5.25e-06	4.42e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TCF7L2—obesity	5.22e-06	4.39e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACLY—obesity	5.2e-06	4.38e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CG—obesity	5.19e-06	4.37e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—DRD2—obesity	5.18e-06	4.36e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GCG—obesity	5.13e-06	4.32e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTPN1—obesity	5.13e-06	4.32e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IRS1—obesity	5.13e-06	4.32e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CD36—obesity	5.11e-06	4.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENPP1—obesity	5.02e-06	4.23e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALOX12—obesity	5.02e-06	4.23e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—obesity	4.95e-06	4.17e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—POMC—obesity	4.94e-06	4.16e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—obesity	4.94e-06	4.16e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—INS—obesity	4.91e-06	4.14e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRL—obesity	4.89e-06	4.12e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—obesity	4.87e-06	4.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMGCS1—obesity	4.86e-06	4.1e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—obesity	4.84e-06	4.08e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—obesity	4.83e-06	4.07e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STK11—obesity	4.82e-06	4.06e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PLG—obesity	4.77e-06	4.02e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1—obesity	4.75e-06	4e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARA—obesity	4.75e-06	4e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT2—obesity	4.75e-06	4e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PLIN1—obesity	4.72e-06	3.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PNPLA2—obesity	4.72e-06	3.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SAT1—obesity	4.72e-06	3.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACADM—obesity	4.72e-06	3.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PFKFB3—obesity	4.72e-06	3.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ANGPTL4—obesity	4.72e-06	3.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FOXO3—obesity	4.65e-06	3.92e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ADRB2—obesity	4.64e-06	3.91e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AGT—obesity	4.6e-06	3.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACACB—obesity	4.59e-06	3.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—OXCT1—obesity	4.59e-06	3.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYTB—obesity	4.59e-06	3.87e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SOCS1—obesity	4.57e-06	3.85e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CD—obesity	4.56e-06	3.84e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—obesity	4.53e-06	3.81e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—PPARG—obesity	4.52e-06	3.81e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SOCS3—obesity	4.52e-06	3.8e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—obesity	4.52e-06	3.8e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SERPINE1—obesity	4.51e-06	3.8e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOE—obesity	4.51e-06	3.8e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PNLIP—obesity	4.48e-06	3.77e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SRD5A1—obesity	4.48e-06	3.77e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CAV1—obesity	4.47e-06	3.76e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—APOA1—obesity	4.46e-06	3.75e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNB3—obesity	4.42e-06	3.72e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—obesity	4.39e-06	3.7e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TYK2—obesity	4.39e-06	3.69e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SDC3—obesity	4.37e-06	3.68e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—RHOA—obesity	4.35e-06	3.66e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF2—obesity	4.34e-06	3.66e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3R1—obesity	4.31e-06	3.63e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOS3—obesity	4.31e-06	3.63e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNAS—obesity	4.3e-06	3.62e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HK2—obesity	4.27e-06	3.6e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—STS—obesity	4.27e-06	3.6e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP26B1—obesity	4.27e-06	3.6e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.27e-06	3.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOB—obesity	4.22e-06	3.55e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—obesity	4.2e-06	3.54e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARD—obesity	4.18e-06	3.52e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL5—obesity	4.12e-06	3.47e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC27A1—obesity	4.09e-06	3.45e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—SERPINE1—obesity	4.07e-06	3.43e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CG—obesity	4.07e-06	3.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LPL—obesity	4.03e-06	3.39e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GLUL—obesity	4.02e-06	3.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FABP4—obesity	4.02e-06	3.38e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FOXO1—obesity	4e-06	3.36e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RPS6KB1—obesity	3.99e-06	3.36e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MTOR—obesity	3.98e-06	3.35e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CB—obesity	3.98e-06	3.35e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PPARG—obesity	3.93e-06	3.31e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—POMC—obesity	3.87e-06	3.26e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—INS—obesity	3.85e-06	3.24e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—obesity	3.84e-06	3.24e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ECHS1—obesity	3.81e-06	3.21e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSD11B1—obesity	3.81e-06	3.21e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UCP2—obesity	3.81e-06	3.21e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UCP3—obesity	3.81e-06	3.21e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADH1B—obesity	3.75e-06	3.15e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—obesity	3.72e-06	3.13e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCD—obesity	3.71e-06	3.12e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPAM—obesity	3.69e-06	3.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARGC1B—obesity	3.69e-06	3.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACSL1—obesity	3.69e-06	3.1e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HTR2A—obesity	3.63e-06	3.06e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—C3—obesity	3.62e-06	3.05e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PCK1—obesity	3.58e-06	3.01e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HADH—obesity	3.58e-06	3.01e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FADS1—obesity	3.58e-06	3.01e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CD—obesity	3.58e-06	3.01e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—obesity	3.53e-06	2.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACP5—obesity	3.48e-06	2.93e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MMP9—obesity	3.46e-06	2.91e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS2—obesity	3.45e-06	2.9e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AGT—obesity	3.44e-06	2.9e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—obesity	3.43e-06	2.89e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—obesity	3.4e-06	2.87e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—G6PD—obesity	3.39e-06	2.86e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NOS3—obesity	3.38e-06	2.84e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3R1—obesity	3.38e-06	2.84e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—LEP—obesity	3.37e-06	2.84e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOE—obesity	3.37e-06	2.84e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK8—obesity	3.36e-06	2.83e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SREBF2—obesity	3.35e-06	2.82e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HK1—obesity	3.35e-06	2.82e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—obesity	3.35e-06	2.82e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CAV1—obesity	3.34e-06	2.81e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—APOA1—obesity	3.34e-06	2.81e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LPA—obesity	3.24e-06	2.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—F2—obesity	3.18e-06	2.68e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCB—obesity	3.18e-06	2.68e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LPIN1—obesity	3.17e-06	2.67e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BAD—obesity	3.14e-06	2.65e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—obesity	3.14e-06	2.64e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CB—obesity	3.12e-06	2.62e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOA5—obesity	3.1e-06	2.61e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—obesity	3.09e-06	2.6e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—obesity	3.07e-06	2.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CG—obesity	3.05e-06	2.56e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—obesity	3.04e-06	2.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IRS1—obesity	3.01e-06	2.53e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CLOCK—obesity	2.96e-06	2.49e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC22A1—obesity	2.96e-06	2.49e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—POMC—obesity	2.9e-06	2.44e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SULT2A1—obesity	2.89e-06	2.43e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GLP1R—obesity	2.89e-06	2.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—INS—obesity	2.88e-06	2.43e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—obesity	2.85e-06	2.4e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—obesity	2.85e-06	2.4e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DPYD—obesity	2.84e-06	2.39e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—obesity	2.84e-06	2.39e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1—obesity	2.79e-06	2.35e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT2—obesity	2.79e-06	2.35e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PRKAR2B—obesity	2.73e-06	2.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DCN—obesity	2.71e-06	2.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CD—obesity	2.68e-06	2.25e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SERPINE1—obesity	2.65e-06	2.23e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CPT1A—obesity	2.64e-06	2.22e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NAMPT—obesity	2.59e-06	2.18e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—obesity	2.58e-06	2.17e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TYK2—obesity	2.58e-06	2.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LIPC—obesity	2.57e-06	2.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCK—obesity	2.57e-06	2.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOC3—obesity	2.56e-06	2.15e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RHOA—obesity	2.55e-06	2.15e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3R1—obesity	2.53e-06	2.13e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOS3—obesity	2.53e-06	2.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CETP—obesity	2.48e-06	2.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SDC1—obesity	2.45e-06	2.07e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—obesity	2.42e-06	2.04e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKR1C3—obesity	2.41e-06	2.03e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SCARB1—obesity	2.38e-06	2e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CB—obesity	2.33e-06	1.96e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MTOR—obesity	2.33e-06	1.96e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—obesity	2.32e-06	1.95e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SREBF1—obesity	2.31e-06	1.94e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GOT2—obesity	2.24e-06	1.89e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FASN—obesity	2.2e-06	1.85e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—BCHE—obesity	2.19e-06	1.84e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—obesity	2.15e-06	1.81e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP2E1—obesity	2.11e-06	1.78e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NQO1—obesity	2.09e-06	1.76e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MMP9—obesity	2.03e-06	1.71e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GCG—obesity	2e-06	1.68e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC2A4—obesity	2e-06	1.68e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—obesity	1.98e-06	1.67e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYCS—obesity	1.97e-06	1.66e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK8—obesity	1.97e-06	1.66e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GGT1—obesity	1.94e-06	1.63e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GOT1—obesity	1.94e-06	1.63e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOA1—obesity	1.91e-06	1.61e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—obesity	1.9e-06	1.6e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP19A1—obesity	1.88e-06	1.58e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—STK11—obesity	1.88e-06	1.58e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—obesity	1.8e-06	1.52e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—obesity	1.79e-06	1.5e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—COMT—obesity	1.75e-06	1.47e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNB3—obesity	1.72e-06	1.45e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARGC1A—obesity	1.72e-06	1.45e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMOX1—obesity	1.72e-06	1.44e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNAS—obesity	1.68e-06	1.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—obesity	1.68e-06	1.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—obesity	1.67e-06	1.41e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOB—obesity	1.64e-06	1.38e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—LPL—obesity	1.57e-06	1.32e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—obesity	1.55e-06	1.31e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPX1—obesity	1.53e-06	1.29e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CD36—obesity	1.49e-06	1.26e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—obesity	1.42e-06	1.2e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—obesity	1.41e-06	1.19e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARA—obesity	1.39e-06	1.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AGT—obesity	1.34e-06	1.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOE—obesity	1.32e-06	1.11e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CAV1—obesity	1.3e-06	1.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—APOA1—obesity	1.3e-06	1.09e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—obesity	1.26e-06	1.06e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CG—obesity	1.19e-06	1e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—obesity	1.16e-06	9.78e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PPARG—obesity	1.15e-06	9.65e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—POMC—obesity	1.13e-06	9.51e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—INS—obesity	1.12e-06	9.46e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CD—obesity	1.04e-06	8.79e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—obesity	1.03e-06	8.67e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3R1—obesity	9.85e-07	8.3e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NOS3—obesity	9.85e-07	8.3e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CB—obesity	9.1e-07	7.66e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—obesity	9.01e-07	7.59e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—obesity	5.54e-07	4.67e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—obesity	4.53e-07	3.81e-06	CbGpPWpGaD
